The global market for Macular Edema Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Macular Edema Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Edema Therapeutics.

The Macular Edema Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macular Edema Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macular Edema Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Macular Edema Therapeutics Market Report

Report Metric	Details
Report Name	Macular Edema Therapeutics Market
CAGR	5%
Segment by Type	Laser Treatment Anti-VEGF Injection Anti-Inflammatory Treatment Vitrectomy
Segment by Application	Cystoid Macular Edema (CME) Diabetic Macular Edema(DME)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Novartis, Roche, Regeneron Pharmaceuticals, Pfizer, Bayer, Boehringer Ingelheim, Bausch & Lomb, Aciont, ActiveSite Pharmaceuticals, Adverum Biotechnologies, Aerpio Therapeutics, Ampio Pharmaceuticals, Araim Pharmaceuticals, Astellas Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macular Edema Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Macular Edema Therapeutics Market report?

Ans: The main players in the Macular Edema Therapeutics Market are Allergan, Novartis, Roche, Regeneron Pharmaceuticals, Pfizer, Bayer, Boehringer Ingelheim, Bausch & Lomb, Aciont, ActiveSite Pharmaceuticals, Adverum Biotechnologies, Aerpio Therapeutics, Ampio Pharmaceuticals, Araim Pharmaceuticals, Astellas Pharma

What are the Application segmentation covered in the Macular Edema Therapeutics Market report?

Ans: The Applications covered in the Macular Edema Therapeutics Market report are Cystoid Macular Edema (CME), Diabetic Macular Edema(DME)

What are the Type segmentation covered in the Macular Edema Therapeutics Market report?

Ans: The Types covered in the Macular Edema Therapeutics Market report are Laser Treatment, Anti-VEGF Injection, Anti-Inflammatory Treatment, Vitrectomy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Laser Treatment

1.2.3 Anti-VEGF Injection

1.2.4 Anti-Inflammatory Treatment

1.2.5 Vitrectomy

1.3 Market by Application

1.3.1 Global Macular Edema Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cystoid Macular Edema (CME)

1.3.3 Diabetic Macular Edema(DME)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Macular Edema Therapeutics Market Perspective (2020-2031)

2.2 Global Macular Edema Therapeutics Growth Trends by Region

2.2.1 Global Macular Edema Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Macular Edema Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Macular Edema Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Macular Edema Therapeutics Market Dynamics

2.3.1 Macular Edema Therapeutics Industry Trends

2.3.2 Macular Edema Therapeutics Market Drivers

2.3.3 Macular Edema Therapeutics Market Challenges

2.3.4 Macular Edema Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Macular Edema Therapeutics Players by Revenue

3.1.1 Global Top Macular Edema Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Macular Edema Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Macular Edema Therapeutics Revenue

3.4 Global Macular Edema Therapeutics Market Concentration Ratio

3.4.1 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Macular Edema Therapeutics Revenue in 2024

3.5 Global Key Players of Macular Edema Therapeutics Head office and Area Served

3.6 Global Key Players of Macular Edema Therapeutics, Product and Application

3.7 Global Key Players of Macular Edema Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Macular Edema Therapeutics Breakdown Data by Type

4.1 Global Macular Edema Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Macular Edema Therapeutics Forecasted Market Size by Type (2026-2031)

5 Macular Edema Therapeutics Breakdown Data by Application

5.1 Global Macular Edema Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Macular Edema Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Macular Edema Therapeutics Market Size (2020-2031)

6.2 North America Macular Edema Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Macular Edema Therapeutics Market Size by Country (2020-2025)

6.4 North America Macular Edema Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Macular Edema Therapeutics Market Size (2020-2031)

7.2 Europe Macular Edema Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Macular Edema Therapeutics Market Size by Country (2020-2025)

7.4 Europe Macular Edema Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Macular Edema Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Macular Edema Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Macular Edema Therapeutics Market Size (2020-2031)

9.2 Latin America Macular Edema Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Macular Edema Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Macular Edema Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Macular Edema Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Macular Edema Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Macular Edema Therapeutics Introduction

11.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2020-2025)

11.1.5 Allergan Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Macular Edema Therapeutics Introduction

11.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Macular Edema Therapeutics Introduction

11.3.4 Roche Revenue in Macular Edema Therapeutics Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Regeneron Pharmaceuticals

11.4.1 Regeneron Pharmaceuticals Company Details

11.4.2 Regeneron Pharmaceuticals Business Overview

11.4.3 Regeneron Pharmaceuticals Macular Edema Therapeutics Introduction

11.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025)

11.4.5 Regeneron Pharmaceuticals Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Macular Edema Therapeutics Introduction

11.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Macular Edema Therapeutics Introduction

11.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2020-2025)

11.6.5 Bayer Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Macular Edema Therapeutics Introduction

11.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2020-2025)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Bausch & Lomb

11.8.1 Bausch & Lomb Company Details

11.8.2 Bausch & Lomb Business Overview

11.8.3 Bausch & Lomb Macular Edema Therapeutics Introduction

11.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2020-2025)

11.8.5 Bausch & Lomb Recent Development

11.9 Aciont

11.9.1 Aciont Company Details

11.9.2 Aciont Business Overview

11.9.3 Aciont Macular Edema Therapeutics Introduction

11.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2020-2025)

11.9.5 Aciont Recent Development

11.10 ActiveSite Pharmaceuticals

11.10.1 ActiveSite Pharmaceuticals Company Details

11.10.2 ActiveSite Pharmaceuticals Business Overview

11.10.3 ActiveSite Pharmaceuticals Macular Edema Therapeutics Introduction

11.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025)

11.10.5 ActiveSite Pharmaceuticals Recent Development

11.11 Adverum Biotechnologies

11.11.1 Adverum Biotechnologies Company Details

11.11.2 Adverum Biotechnologies Business Overview

11.11.3 Adverum Biotechnologies Macular Edema Therapeutics Introduction

11.11.4 Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2020-2025)

11.11.5 Adverum Biotechnologies Recent Development

11.12 Aerpio Therapeutics

11.12.1 Aerpio Therapeutics Company Details

11.12.2 Aerpio Therapeutics Business Overview

11.12.3 Aerpio Therapeutics Macular Edema Therapeutics Introduction

11.12.4 Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2020-2025)

11.12.5 Aerpio Therapeutics Recent Development

11.13 Ampio Pharmaceuticals

11.13.1 Ampio Pharmaceuticals Company Details

11.13.2 Ampio Pharmaceuticals Business Overview

11.13.3 Ampio Pharmaceuticals Macular Edema Therapeutics Introduction

11.13.4 Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025)

11.13.5 Ampio Pharmaceuticals Recent Development

11.14 Araim Pharmaceuticals

11.14.1 Araim Pharmaceuticals Company Details

11.14.2 Araim Pharmaceuticals Business Overview

11.14.3 Araim Pharmaceuticals Macular Edema Therapeutics Introduction

11.14.4 Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025)

11.14.5 Araim Pharmaceuticals Recent Development

11.15 Astellas Pharma

11.15.1 Astellas Pharma Company Details

11.15.2 Astellas Pharma Business Overview

11.15.3 Astellas Pharma Macular Edema Therapeutics Introduction

11.15.4 Astellas Pharma Revenue in Macular Edema Therapeutics Business (2020-2025)

11.15.5 Astellas Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Allergan plc

Novartis

Roche

Regeneron Pharmaceuticals

ActiveSite Pharmaceuticals

Adverum Biotechnologies

Aerpio Therapeutics

Ampio Pharmaceuticals

Araim Pharmaceuticals

Astellas Pharma

List of Tables

Table 1. Global Macular Edema Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Laser Treatment

Table 3. Key Players of Anti-VEGF Injection

Table 4. Key Players of Anti-Inflammatory Treatment

Table 5. Key Players of Vitrectomy

Table 6. Global Macular Edema Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Macular Edema Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Macular Edema Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Macular Edema Therapeutics Market Share by Region (2020-2025)

Table 10. Global Macular Edema Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Macular Edema Therapeutics Market Share by Region (2026-2031)

Table 12. Macular Edema Therapeutics Market Trends

Table 13. Macular Edema Therapeutics Market Drivers

Table 14. Macular Edema Therapeutics Market Challenges

Table 15. Macular Edema Therapeutics Market Restraints

Table 16. Global Macular Edema Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Macular Edema Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema Therapeutics as of 2024)

Table 19. Ranking of Global Top Macular Edema Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Macular Edema Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Macular Edema Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Macular Edema Therapeutics, Product and Application

Table 23. Global Key Players of Macular Edema Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Macular Edema Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Macular Edema Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global Macular Edema Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Macular Edema Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global Macular Edema Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Macular Edema Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global Macular Edema Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Macular Edema Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Macular Edema Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Macular Edema Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Macular Edema Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Macular Edema Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Macular Edema Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Macular Edema Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Macular Edema Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Allergan Company Details

Table 49. Allergan Business Overview

Table 50. Allergan Macular Edema Therapeutics Product

Table 51. Allergan Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 52. Allergan Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Macular Edema Therapeutics Product

Table 56. Novartis Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Roche Company Details

Table 59. Roche Business Overview

Table 60. Roche Macular Edema Therapeutics Product

Table 61. Roche Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Roche Recent Development

Table 63. Regeneron Pharmaceuticals Company Details

Table 64. Regeneron Pharmaceuticals Business Overview

Table 65. Regeneron Pharmaceuticals Macular Edema Therapeutics Product

Table 66. Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 67. Regeneron Pharmaceuticals Recent Development

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer Macular Edema Therapeutics Product

Table 71. Pfizer Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Pfizer Recent Development

Table 73. Bayer Company Details

Table 74. Bayer Business Overview

Table 75. Bayer Macular Edema Therapeutics Product

Table 76. Bayer Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Bayer Recent Development

Table 78. Boehringer Ingelheim Company Details

Table 79. Boehringer Ingelheim Business Overview

Table 80. Boehringer Ingelheim Macular Edema Therapeutics Product

Table 81. Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 82. Boehringer Ingelheim Recent Development

Table 83. Bausch & Lomb Company Details

Table 84. Bausch & Lomb Business Overview

Table 85. Bausch & Lomb Macular Edema Therapeutics Product

Table 86. Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 87. Bausch & Lomb Recent Development

Table 88. Aciont Company Details

Table 89. Aciont Business Overview

Table 90. Aciont Macular Edema Therapeutics Product

Table 91. Aciont Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 92. Aciont Recent Development

Table 93. ActiveSite Pharmaceuticals Company Details

Table 94. ActiveSite Pharmaceuticals Business Overview

Table 95. ActiveSite Pharmaceuticals Macular Edema Therapeutics Product

Table 96. ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 97. ActiveSite Pharmaceuticals Recent Development

Table 98. Adverum Biotechnologies Company Details

Table 99. Adverum Biotechnologies Business Overview

Table 100. Adverum Biotechnologies Macular Edema Therapeutics Product

Table 101. Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 102. Adverum Biotechnologies Recent Development

Table 103. Aerpio Therapeutics Company Details

Table 104. Aerpio Therapeutics Business Overview

Table 105. Aerpio Therapeutics Macular Edema Therapeutics Product

Table 106. Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 107. Aerpio Therapeutics Recent Development

Table 108. Ampio Pharmaceuticals Company Details

Table 109. Ampio Pharmaceuticals Business Overview

Table 110. Ampio Pharmaceuticals Macular Edema Therapeutics Product

Table 111. Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 112. Ampio Pharmaceuticals Recent Development

Table 113. Araim Pharmaceuticals Company Details

Table 114. Araim Pharmaceuticals Business Overview

Table 115. Araim Pharmaceuticals Macular Edema Therapeutics Product

Table 116. Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 117. Araim Pharmaceuticals Recent Development

Table 118. Astellas Pharma Company Details

Table 119. Astellas Pharma Business Overview

Table 120. Astellas Pharma Macular Edema Therapeutics Product

Table 121. Astellas Pharma Revenue in Macular Edema Therapeutics Business (2020-2025) & (US$ Million)

Table 122. Astellas Pharma Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Macular Edema Therapeutics Picture

Figure 2. Global Macular Edema Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Macular Edema Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Laser Treatment Features

Figure 5. Anti-VEGF Injection Features

Figure 6. Anti-Inflammatory Treatment Features

Figure 7. Vitrectomy Features

Figure 8. Global Macular Edema Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Macular Edema Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Cystoid Macular Edema (CME) Case Studies

Figure 11. Diabetic Macular Edema(DME) Case Studies

Figure 12. Macular Edema Therapeutics Report Years Considered

Figure 13. Global Macular Edema Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Macular Edema Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Macular Edema Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Macular Edema Therapeutics Market Share by Players in 2024

Figure 17. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Macular Edema Therapeutics Revenue in 2024

Figure 19. North America Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Macular Edema Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Macular Edema Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Macular Edema Therapeutics Market Share by Region (2020-2031)

Figure 33. China Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Macular Edema Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Macular Edema Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Macular Edema Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 51. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 53. Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 54. Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 55. Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 56. Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 57. ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 58. Adverum Biotechnologies Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 59. Aerpio Therapeutics Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 60. Ampio Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 61. Araim Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 62. Astellas Pharma Revenue Growth Rate in Macular Edema Therapeutics Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13L12609

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32B20021

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38C19846

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2H20253

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions